JENNA JACOBSON: Open Payments
NPI 1184247165 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,872 in 86 payments from 16 companies in 2025. Trend: 2023 $1,522 · 2024 $2,067 · 2025 $1,872
Food & beverage: $1,872
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $511 |
| ABBVIE INC. | 21 | $264 |
| Axsome Therapeutics, Inc. | 11 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $217 |
| TMS NeuroHealth Centers Inc. | 3 | $113 |
| Bausch Health US, LLC | 5 | $103 |
| Lundbeck LLC | 5 | $87 |
| Teva Pharmaceuticals USA, Inc. | 2 | $70 |
| Corium, LLC | 2 | $52 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
Products named: REXULTI, VRAYLAR, Auvelity, CAPLYTA, TMS NeuroHealth Centers Inc., APLENZIN, AUSTEDO XR, Azstarys.
Industry payments across IL — which companies pay providers there.
